Avinger (AVGR)
(Delayed Data from NSDQ)
$0.78 USD
0.00 (0.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.28%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$0.78 USD
0.00 (0.00%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.28%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Zacks News
PharMerica Takes Over CareMed, Expands in Specialty Pharmacy
by Zacks Equity Research
PharMerica Corporation (PMC) recently announced the acquisition of CareMed Specialty Pharmacy, a leading provider of specialty pharmacy services. However, all the other terms of the deal have been kept under wraps.
Air Methods (AIRM) Opens New Training Facility in Colorado
by Zacks Equity Research
Air Methods Corporation (AIRM) announced the opening of new FlightSafety Learning Center in Denver, CO.
Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike
by Zacks Equity Research
Patterson Companies Inc. (PDCO) recently hiked its quarterly dividend by 8% to 26 cents per share from 24 cents.
Air Methods (AIRM) Set to be Acquired for $2.5 Billion
by Zacks Equity Research
Air Methods Corporation (AIRM) announced that it is set to be acquired by New York-based private equity firm American Securities LLC for $2.5 billion.
AngioDynamics Microwave Tissue Ablation System Now CE Marked
by Zacks Equity Research
AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, recently announced the receipt of CE mark for Solero Microwave Tissue Ablation (MTA) System.
Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty
by Zacks Equity Research
Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.
Ensign Group Signs Lease Agreement with Mainstreet Health
by Zacks Equity Research
The Ensign Group, Inc. (ENSG) recently signed definitive agreements to simultaneously sell and lease two skilled nursing facilities and one assisted living community to Mainstreet Health Investments Inc.
Is it Wise to Hold Universal Health (UHS) in Your Portfolio?
by Zacks Equity Research
Headquartered in King of Prussia, PA, Universal Health Services Inc. (UHS) stock has gained 12.8% year to date, significantly higher than the increase of 7.6% witnessed by the Zacks categorized medical sector.
Tenet Healthcare (THC) Signs Multi-Year Deal with BCBSTX
by Zacks Equity Research
Tenet Healthcare Corporation (THC) recently inked a deal with Blue Cross and Blue Shield of Texas ("BCBSTX").
Cantel Medical (CMD) Q2 Earnings & Sales Grow Year Over Year
by Zacks Equity Research
Cantel Medical Corp. (CMD) reported adjusted earnings of 52 cents per share in the second quarter of fiscal 2017.
ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
by Zacks Equity Research
A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).
Humana's Subsidiaries Receive Rating Action from A.M. Best
by Zacks Equity Research
Humana Inc. (HUM) recently received rating action from A.M. Best. The rating giant has removed from under review, with positive implications, the majority of insurance subsidiaries of the company.
UnitedHealth's Senior Unsecured Notes Rated by A.M Best
by Zacks Equity Research
UnitedHealth Group, Inc.'s (UNH) senior unsecured notes recently received rating action from A.M Best.
Cooper Companies (COO) Receives ISO 15189 Accreditation
by Zacks Equity Research
The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.
C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
by Zacks Equity Research
We issued an updated research report on C. R. Bard Inc. (BCR) on Mar 8, 2017.
UnitedHealth's (UNH) Senior Unsecured Debt Rated by Moody's
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) recently announced that its senior unsecured debt has been assigned an A3 rating by Moody's Investors Service, a wing of Moody???s Corporation (MCO).
Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Baxter International Inc. (BAX), a global medical technology company, rallied to a new 52-week high of $51.43 on Mar 8, eventually closing a bit lower at $51.36.
Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up
by Zacks Equity Research
Intersect ENT, Inc (XENT) recently announced the submission of a New Drug Application (NDA) approval with the U.S. FDA for reviewing its investigational RESOLVE steroid releasing implant.
OPKO Health (OPK) Launches Prenatal Testing Tool ClariTest
by Zacks Equity Research
OPKO Health Inc. (OPK) recently announced the launch of a non-invasive medical test to detect fetal abnormalities.
Community Health Prices Senior Secured Notes Worth $2.2B
by Zacks Equity Research
Community Health Systems, Inc. (CYH) recently announced that it has issued 6.25%, $2.2 billion Senior Secured Notes, due 2023. The offering was upsized by $450 million.
Meridian (VIVO) to Provide LeadCare Testing System in Africa
by Zacks Equity Research
Meridian Bioscience, Inc. (VIVO), a renowned life sciences company, recently signed an exclusive distribution agreement with Biofirm Technologies.
TransEnterix (TRXC) Reports Wider-Than-Expected Loss in Q4
by Zacks Equity Research
TransEnterix, Inc. (TRXC) reported a loss of 12 cents per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of 11 cents.
Masimo Announces Availability of RD SedLine Brain Sensors
by Zacks Equity Research
Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.
Allscripts (MDRX) Acknowledged by LPP's CDIS Framework
by Zacks Equity Research
Allscripts Healthcare Solutions, Inc. (MDRX) recently announced that it has been accepted and acknowledged by the NHS London Procurement Partnership (LPP) in its Clinical and Digital Information Systems (CDIS) Framework.
DexCom (DXCM) Incurs Narrower Loss in Q4, Beats on Revenues
by Zacks Equity Research
DexCom Inc. (DXCM) reported loss of nine cents per share in the fourth quarter of 2016, narrower than the Zacks Consensus Estimate of a loss of 10 cents.